MIRA INFORM REPORT

 

 

Report No. :

335938

Report Date :

13.08.2015

 

IDENTIFICATION DETAILS

 

Name :

PLURIPHARM SA

 

 

Registered Office :

88b, Ave John Brown, Port-au-Prince, Haiti

 

 

Country :

Haiti

 

 

Date of Incorporation :

November 1995

 

 

Legal Form :

Sociedad Anónima

 

 

Line of Business :

Subject  is import and sale of pharmaceutical products and medical equipment

 

 

No. of Employee :

35

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Haiti

B2

B2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

HAITI - ECONOMIC OVERVIEW

 

Haiti is a free market economy that enjoys the advantages of low labor costs and tariff-free access to the US for many of its exports. Poverty, corruption, vulnerability to natural disasters, and low levels of education for much of the population are among Haiti's most serious impediments to economic growth. Haiti's economy suffered a severe setback in January 2010 when a 7.0 magnitude earthquake destroyed much of its capital city, Port-au-Prince, and neighboring areas. Currently the poorest country in the Western Hemisphere with 80% of the population living under the poverty line and 54% in abject poverty, the earthquake further inflicted $7.8 billion in damage and caused the country's GDP to contract. In 2011, the Haitian economy began recovering from the earthquake. However, two hurricanes adversely affected agricultural output and the low public capital spending slowed the recovery in 2012. Two-fifths of all Haitians depend on the agricultural sector, mainly small-scale subsistence farming, and remain vulnerable to damage from frequent natural disasters, exacerbated by the country's widespread deforestation. US economic engagement under the Caribbean Basin Trade Preference Agreement (CBTPA) and the 2008 Haitian Hemispheric Opportunity through Partnership Encouragement (HOPE II) Act helped increase apparel exports and investment by providing duty-free access to the US. Congress voted in 2010 to extend the CBTPA and HOPE II until 2020 under the Haiti Economic Lift Program (HELP) Act; the apparel sector accounts for about 90% of Haitian exports and nearly one-twentieth of GDP. Remittances are the primary source of foreign exchange, equaling one-fifth of GDP and representing more than five times the earnings from exports in 2012. Haiti suffers from a lack of investment, partly because of weak infrastructure such as access to electricity. Haiti's outstanding external debt was cancelled by donor countries following the 2010 earthquake, but has since risen to $1.43 billion as of December 2014. The government relies on formal international economic assistance for fiscal sustainability, with over half of its annual budget coming from outside sources.

 

Source : CIA

 


 

STATUTORY INFORMATION

Legal Name:

PLURIPHARM SA

Trade Name:

Pluripharm

NIF:

000-092-170-4

Date Created:

1995

Date Incorporated:

Nov-95

Legal Address:

88b, Ave John Brown

Port-au-Prince, Haiti

Operative Address:

88b, Ave John Brown

Port-au-Prince, Haiti

Telephone:

509 222 9806, 509 222 3404, 509 222 313

Fax:

509 222 9806

Legal Form:

Sociedad Anónima

Email:

info@pluripharmsa.com /pluripharmsa@gmail.com

Registered in:

Haiti

Website:

www.pluripharmsa.com

Contact:

Jean Karl CAVE

Staff:

35

Activity:

Pharmaceuticals, Medical Equipment, Health, Medicine and Recreation

 

 

 

 

BANKS

 

Banque de la République d'Haïti

 

 

 The company does not make its banking data public

 

 

History

 

Pluripharm S.A. is the result of the merger between two previously individually owned companies.

 

One, specializing in pharmaceutical products, I.V. solutions and some other over-the-counter popular brand names, owned by Mr. Robert Brisson and his wife. The second, mostly involved in paramedical products and hospital equipment as a whole, property of Mr. Karl Cavé and his brother in law Mr. Edouard Legagneur.

 

These individual units had been operating in the Haitian market since 1991 until the three owners decided to merge, and incorporate their assets under the name PLURIPHARM S.A. in October 1995.

 

 

PRINCIPAL ACTIVITY

 The company is dedicated to the import and sale of pharmaceutical products and medical equipment.

Products/Services description:

Medical equipments. Pharmaceutical products, hospital equipments, laboratory reagents and materials

Brands:

LifeStraw®

Sales are:

Wholesale

Clients:

Pharmaceutical industry

Suppliers:

Geno Pharmaceuticals Ltd.

India

Operations area:

National

The company imports from

Dominican Republic, India, Netherlands, United States

The company exports to

No exports

The subject employs

35 employees

Payments:

Slow

 

 

 

 

LOCATION

Headquarters :

88b, Ave John Brown

Port-au-Prince, Haiti

Branches:

The company does not have branches

Industry:

 

 

 

GROUP STRUCTURE AND SUBSIDIARY COMPANIES

Listed at the stock exchange:

NO

Capital:

NA

Shareholders:

Owners: Jean Karl CAVE, Edouard LEGAGNEUR, Robert BRISSON

Management:

Jean Karl CAVE, Director

Edouard LEGAGNEUR, Manager

Robert BRISSON, Manager

 

 

FINANCIAL INFORMATION

 The company does not make its financial figures public.

  

 There are no financial for the subject

 

LEGAL FILINGS

 

 

 There are no legal connected to the subject

 

 

 

 

SUMMARY

 

 

The company is dedicated to the import and sale of pharmaceutical products and medical equipment.

 

The company has a small-medium sized structure with 20 years of experience in the market.

 

It is managed by its owners, and mainly imports from India.

 

There are no negative records connected to the subject; however, it is important to consider Haitian financial situation.

 

 

RISK INFORMATION

 Haiti remains the poorest country in the Americas and one of the poorest in the world (with a GDP per capita of US$ 846 in 2014) with significant needs in basic services. According to the latest household survey (ECVMAS 2012), more than 6 million out of 10.4 million (59%) Haitians live under the national poverty line of $ 2.44 per day and over 2.5 million (24%) live under the national extreme poverty line of 1.24 dollar per day It is also one of the most unequal countries, with a Gini coefficient of 0.61 as of 2012.

 

 

DEBTS

Controlled

PAYMENTS

Slow

CASH FLOW

Normal

STATUS

Active

 

 

INTERVIEW

NAME

NA 

POSITION

Administrative 

COMMENTS

He confirmed address, activity, managers. He refused to provide more data. 

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.64.83

UK Pound

1

Rs.101.00

Euro

1

Rs.71.82

 

INFORMATION DETAILS

 

Analysis Done by :

KAS

 

 

Report Prepared by :

ASH

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.